On July 6th, 2021, Kura Oncology (NASDAQ: KURA) announced a clinical collaboration with Novartis to evaluate the combination of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE